COMMUNIQUÉS West-GlobeNewswire

Scilex Holding Company Announces the Continuing Support from Endeavor Distribution LLC in the Multi-Year Agreement for Scilex’s Commercial Products and the Satisfaction of FSF 33433 LLC $10 Million Loan

18/09/2024 - 15:00

PALO ALTO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]

GRI Bio Participates in Virtual Investor KOL Connect Segment

18/09/2024 - 15:00

Albert Agro, PhD, CMO of GRI Bio recently participated in a Virtual Investor KOL Connect segment with prominent key opinion leader in Idiopathic Pulmonary Fibrosis (IPF) – Dr. Helen Parfrey, Respiratory Consultant at [...]

NEXGEL's Beauty Brand, Silly George, Partners with Multi-Talented Artist and Entrepreneur, James Maslow, to Promote Innovative Eyelash Collection

18/09/2024 - 15:00

LANGHORNE, Pa., Sept. 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]

Corza Medical Named to the 2024 MedTech Big 100 List

18/09/2024 - 14:55

WESTWOOD, Mass., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”), a leading global medical technology company committed to remarkable service, trusted performance and outstanding value, is [...]

Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer

18/09/2024 - 14:54

- Transaction Will Maximize the Access and Uptake of COSELA ® (trilaciclib), the First and Only Proactive Multilineage Myeloprotection Agent - - G1 Stockholders to Receive U.S. $7.15 Per Share in Cash - HOLBAEK, Denmark [...]

Notice of Annual General Meeting 2024

18/09/2024 - 14:45

ANNOUNCEMENT NO. 275 18 September 2024 Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 10 October 2024 at 5.30 p.m. The general meeting will be held [...]

Revolo Announces New Preclinical Data Further Validating Atopic Dermatitis as a Target Indication for ‘1104

18/09/2024 - 14:45

Data continues to differentiate ‘1104 as a potential allergic disease treatment that acts upstream in the immune cascade ‘1104 reduces key indices of skin inflammation and inflammatory mediators in a chronic allergen- [...]

Ketabon To Present Advancements In At-Home Ketamine Therapy For Treatment-Resistant Depression At ECNP Congress 2024

18/09/2024 - 14:30

Presentations Will Highlight Oral Prolonged-Release Ketamine (KET01) And its Minimal Impact on Sleep, Alongside Excellent Day-One Tolerability in Patients MUNICH, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ketabon GmbH (“ [...]

Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors

18/09/2024 - 14:30

SON-1010 is a targeted immune activation cancer therapy designed to turn ‘cold’ tumors ‘hot’ Topline safety data of SB101 Phase 1 study expected by Q4 2024 PRINCETON, NJ, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Sonnet [...]

Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing

18/09/2024 - 14:30

New Biological Data Released from IRO® Cell Therapy Manufacturing Platform PHILADELPHIA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, [...]

Femasys Announces Infertility Clinic Customers from Coast to Coast

18/09/2024 - 14:30

Leading medical clinics become key regional resources to offer FemaSeed infertility treatment ATLANTA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing [...]

BioCardia Regains Full Compliance with Nasdaq Listing Requirements

18/09/2024 - 14:30

SUNNYVALE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today [...]

Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds

18/09/2024 - 14:30

ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative [...]

Procaps Issues Shareholder Letter Update

18/09/2024 - 14:10

MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services, today issued the [...]

Kairos Pharma Closing of $6.2 Million Initial Public Offering

17/09/2024 - 22:29

LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”) (NYSE American: KAPA), a clinical stage biopharmaceutical company developing cancer therapeutics designed to reverse [...]

Independent Directors of 23andMe Resign from Board

17/09/2024 - 22:26

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki, Chief Executive Officer, Co- [...]

Traws Pharma, Inc. Announces Special Shareholders Meeting Results

17/09/2024 - 22:05

Three proposals, including a reverse stock split, were submitted and approved Traws Board subsequently approved a 1-for-25 reverse stock split Traws’ shares expected to begin trading on a split-adjusted basis on [...]

Jushi Holdings Inc. Announces Options Issued to Executive Officers

17/09/2024 - 22:05

BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, is pleased to announce that [...]

RadNet, Inc. to Present at the Sidoti & Company Small Cap 2024 Virtual Conference on Wednesday, September 18th

17/09/2024 - 22:05

LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]